MedTrace Logo

Combination Medications vs. Patch Alone for Medically-Ill Smokers

NCT00770666 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 127

Last updated 2008-10-10

No results posted yet for this study

Summary

Randomized clinical trial to evaluate a flexibly-dosed-3-medication combination for up to 6 months in smokers with medical illness

Conditions

  • Smoking Cessation

Interventions

DRUG

Nicotine patch, nicotine inhaler, bupropion

Patch - 21 mg - taper as able Inhaler - as needed Bupropion SR 150 mg daily

DRUG

Nicotine patch

21 mg daily for 6 weeks followed by 14 mg for 2 weeks and then 7 mg for 2 weeks

Sponsors & Collaborators

  • Rutgers Cancer Institute of New Jersey

    collaborator OTHER

  • Robert Wood Johnson Foundation

    collaborator OTHER

  • University of Medicine and Dentistry of New Jersey

    lead OTHER

Principal Investigators

  • Michael B Steinberg, MD, MPH · UMDNJ-RWJMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2007-12-31
Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00770666 on ClinicalTrials.gov